MARASTONI, DAMIANO
 Distribuzione geografica
Continente #
NA - Nord America 612
EU - Europa 413
AS - Asia 164
OC - Oceania 3
SA - Sud America 3
AF - Africa 2
Totale 1.197
Nazione #
US - Stati Uniti d'America 611
CN - Cina 119
IT - Italia 79
SE - Svezia 69
IE - Irlanda 64
GB - Regno Unito 63
FR - Francia 56
DE - Germania 34
FI - Finlandia 28
VN - Vietnam 25
KR - Corea 6
NL - Olanda 6
UA - Ucraina 5
BE - Belgio 4
HK - Hong Kong 4
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AU - Australia 2
CH - Svizzera 2
LA - Repubblica Popolare Democratica del Laos 2
SC - Seychelles 2
BD - Bangladesh 1
CA - Canada 1
CL - Cile 1
IM - Isola di Man 1
IR - Iran 1
KG - Kirghizistan 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SG - Singapore 1
TH - Thailandia 1
TR - Turchia 1
Totale 1.197
Città #
Chandler 204
Dublin 62
Ashburn 59
Southend 59
Redmond 39
Verona 37
Princeton 29
Helsinki 23
Beijing 22
Jacksonville 22
Lawrence 22
Dong Ket 20
New York 19
Sindelfingen 16
Jinan 11
Wilmington 11
Woodbridge 11
Ann Arbor 8
Tianjin 8
Washington 8
Redwood City 7
Taizhou 7
Guangzhou 6
Nanjing 6
Seoul 6
Duncan 5
Lappeenranta 5
Norwalk 5
Seattle 5
Shenyang 5
Brussels 4
Dongguan 4
Fairfield 4
Hebei 4
Hong Kong 4
Pordenone 4
Taiyuan 4
Amsterdam 3
Haikou 3
Houston 3
Los Angeles 3
Milan 3
Ningbo 3
Padova 3
Rome 3
Roverbella 3
Zhengzhou 3
Atlanta 2
Bonndorf 2
Buenos Aires 2
Cambridge 2
Changsha 2
Fuzhou 2
Hangzhou 2
Lanzhou 2
London 2
Nanchang 2
Oppeano 2
San Diego 2
Vientiane 2
Zurich 2
Ardabil 1
Auckland 1
Bangkok 1
Bishkek 1
Bologna 1
Boydton 1
Chicago 1
Chisinau 1
Clearwater 1
Dearborn 1
Dhaka 1
Douglas 1
Groningen 1
Hanoi 1
Kemerovo 1
Laredo 1
Las Vegas 1
Littleton 1
Mahé 1
Mehlingen 1
Philadelphia 1
Pieve di Soligo 1
Radeberg 1
Riva 1
Rockville 1
San Francisco 1
Santiago 1
Shenzhen 1
Singapore 1
Telgate 1
Toronto 1
Trento 1
Valenciennes 1
Willaston 1
Totale 867
Nome #
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 79
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 79
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 72
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 62
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 62
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 59
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 59
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 56
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 54
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 53
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 51
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 50
Sustained response to subcutaneous immunoglobulins in chronic ataxic neuropathy with anti-disialosyl IgM antibodies (CANDA): report of two cases and review of the literature 49
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 45
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy 44
Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter 44
The BAFF / APRIL system as therapeutic target in multiple sclerosis 39
Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients 34
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients 33
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis 32
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis 30
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 30
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 29
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 21
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 20
Prominent role of executive functioning on the Phonemic Fluency Test in people with multiple sclerosis 13
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: a 20-year study 13
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 12
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 7
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 6
High levels of perivascular inflammation and active demyelinating lesions at time of death associated with rapidly progressive multiple sclerosis disease course: a retrospective post-mortem cohort study 5
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 4
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis 3
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 2
Totale 1.251
Categoria #
all - tutte 5.775
article - articoli 5.717
book - libri 0
conference - conferenze 58
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.550


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/202064 3 3 3 1 16 3 3 1 0 1 16 14
2020/2021141 15 9 9 17 19 11 7 2 9 1 18 24
2021/2022217 6 65 0 51 2 1 9 10 5 19 11 38
2022/2023505 33 74 34 93 29 113 5 38 60 3 11 12
2023/2024283 11 20 22 53 29 71 24 13 6 33 1 0
Totale 1.251